Galveston National Laboratory
Center for Biodefense & Emerging Infectious Diseases
Sealy Center for Vaccine Development
Center for Tropical Diseases
McLaughlin Endowment for Infection and Immunity |
 |
 |
 |
 |
The newly funded UTMB Clinical Proteomics Center (CPC) seeks to provide a collaborative resource…
March 3, 2009
The newly funded UTMB Clinical Proteomics Center (CPC) seeks to provide a collaborative resource that supports the discovery, qualification and verification of human protein biomarkers induced by infection with NIAID Category A-C agents and new/emerging infectious agents. Work in the center will include application of a protein biomarker discovery platform that produces quantitative pre-fractionation, 2-dimensional gel electrophoresis (2DE) and tandem liquid chromatography (LC)-mass spectrometry (MS)-based protein identification. Bioinformatics tools will be used to develop predictive models of infectious outcomes that will drive further studies in validation by collaborating investigators. Work in the center will also include development of platforms for biomarker qualification and verification. Interested investigators can submit short pre-proposals that will be developed into full projects upon approval of the scientific working group and NIAID. Preproposals are now being accepted. Visit our web site for further information.